Kohlberg & Co. to merge Bemis® Healthcare Packaging with Nelipak
Category: #business  By Pankaj Singh  Date: 2019-08-10
  • share
  • Twitter
  • Facebook
  • LinkedIn

Kohlberg & Co. to merge Bemis® Healthcare Packaging with Nelipak

Bemis® will be incorporated with Nelipak and jointly operate under the Nelipak® Healthcare Packaging brand.

Nelipak® Corporation, Inc., a company that focuses on providing custom packaging for pharmaceutical and medical industries, recently announced that its parent firm Kohlberg & Company, L.L.C., an American private equity firm focused on leveraging buyout transactions, have finalized the acquisition of Bemis® Healthcare Packaging Europe from Amcor’s packaging business unit.

According to reports, Bemis® which is located in Derry (Northern Ireland, UK), Elsham (United Kingdom) and Clara (Ireland) which will be merged with Nelipak and the joint company will operate under the Nelipak® Healthcare Packaging brand.

Speaking on the move, Mike Kelly, President and CEO, Nelipak, said that the company is excited with its merger with Bemis® European Healthcare Packaging business, a firm with tremendous capabilities and workforce, and is delighted to welcome its team into Nelipak.

He said that their firm will leverage the unique capabilities of both firms to fulfill their customer’s requirement with world-class quality, innovative design and excellent service. He further claims that the merger would enhance Nelipak’s knowhow and provide flexible packaging options for their global customers.

According to Roger Prevot, Operating Partner, Kohlberg, the Bemis acquisition would offer new prospects to develop global scale and diversification across complementary product offerings. He claims that this merger would offer attractive opportunities for revenue growth from cross-selling and geographic expansions. Moreover, Mike and his team will become better equipped to serve the firm’s clients as a comprehensive partner for their packaging needs, he added.

For the uninitiated, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that offer superior protection for pharmaceuticals and medical devices. Its customers include some of the largest medical device and pharmaceutical companies in the world.

As for Kohlberg & Co., the company is located in Mount Kisco, New York and is a leading private equity firm that has managed to raise over $7.5 billion of committed equity capital.

Source Credit: http://www.nelipak.com/news/kohlberg-closes-on-acquisition-of-bemis-healthcare-packaging-europe-merges-with-nelipak/

 

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Yumanity starts Phase 1 trial of YTX-7739 to treat Parkinson’s disease
Yumanity starts Phase 1 trial of YTX-7739 to treat Parkinson’s disease
By Pankaj Singh

Number of cases where people are affected with neurodegenerative diseases have been growing at a substantial pace. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases found across the world. Various ...

AngioDynamics buys Eximo Medical and its 355nm Laser Atherectomy tech
AngioDynamics buys Eximo Medical and its 355nm Laser Atherectomy tech
By Pankaj Singh

Owing to widescale tobacco use, the world is seeing an increased number of cancer and vascular diseases. India alone registers more than 10 million cases of peripheral artery disease on an annual basis. Technology and healthcare enterprises are incre...

Scholar Rock to showcase preclinical, phase 1 clinical data of SRK-015
Scholar Rock to showcase preclinical, phase 1 clinical data of SRK-015
By Pankaj Singh

SMA is a rare genetic disease that typically affects young children. Currently, there is no cure for spinal muscular atrophy (SMA), however, various pharmaceutical firms across the world are working to discover a novel, innovative treatment for the d...